Original Research
Accepted on 21 Apr 2026
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false positives results in the BD MGIT 960 assay and added value of sequencing in accurate diagnosis in a low MDR-TB incidence context
in Antibiotic Resistance and New Antimicrobial drugs